TANJU BERBER

Dr. TANJU BERBER

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 October 2022 in Journal of Radiation Research
Verified
Journal Article
Open access
PDF file
TBTANJU BERBER
TANJU BERBER
SCSuat Erol Celik
Suat Erol Celik
FAFerdi Aksaray
Ferdi Aksaray
AYAdnan Yoney
Adnan Yoney
KHKemal Harmanci
Kemal Harmanci
BYBerna Akkuş Yıldırım
Berna Akkuş Yıldırım
In this study, the dose schedule efficacy, safety and late adverse effects of stereotactic radiosurgery (SRS) were evaluated for patients with symptomatic cavernomas who were not eligible for surgery and treated with SRS. Between January 2013 and December 2018, 53 patients with cavernomas were treated using SRS with the CyberKnife® system. Patients’ diseases were deeply located or were in subcortical functional brain regions. In addition to bleeding, 23 (43.4%) patients had epilepsy, 12 (22.6%) had neurologic symptoms and 16 patients (30.2%) had severe headaches. The median volume was 741 (range, 421–1351) mm3, and the median dose was 15 (range, 14–16) Gy in one fraction. After treatment, six (50%) of 12 patients with neurologic deficits still had deficits. Rebleeding after treatment developed in only two (3.8%) patients. The drug was completely stopped in 14 (60.9%) out of 23 patients who received epilepsy treatment, and the dose of levetiracetam decreased from 2000 mg to 1000 mg in four (17.3%) of nine patients. Radiologically, complete response (CR) was observed in 13 (24.5%) patients, and partial responses (PR) were observed in 32 (60.2%) patients. Clinical response of CR was observed in 30 (56.6%) patients, PR was observed in 16 (30.2%), stable disease (SD) was observed in three (5.7%) and four (7.5%) patients progressed. In conclusion, SRS applied in the appropriate dose schedule may be an effective and reliable method in terms of symptom control and prevention of rebleeding, especially in patients with inoperable cavernomas.

30 September 2022 in European Spine Journal
Verified
Journal Article
Closed access
PDF file
TBTANJU BERBER
TANJU BERBER
ÇNÇakır Numanoğlu
Çakır Numanoğlu
EUEmre Uysal
Emre Uysal
SDSelvi Dinçer
Selvi Dinçer
BYBerna Akkuş Yıldırım
Berna Akkuş Yıldırım

1 July 2021 in Cancer/Radiothérapie
Verified
Journal Article
Closed access
TBTANJU BERBER
TANJU BERBER
VRVijay Raturi
Vijay Raturi
FAF. Aksaray
F. Aksaray
HHH. Hojo
H. Hojo
TFT. Fujisawa
T. Fujisawa
HOH. Ohyoshi
H. Ohyoshi

1 January 2021 in The Aging Male
Verified
Journal Article
Open access
SDSelvi Dinçer
Selvi Dinçer
EUEmre Uysal
Emre Uysal
TBTANJU BERBER
TANJU BERBER
MAMustafa Halil Akboru
Mustafa Halil Akboru
We aimed to investigate the efficacy and tolerability of ultra-hypofractionated radiotherapy (UHRT) in the treatment of low and intermediate-risk prostate cancer patients.This retrospective study w...

23 March 2023 in TURKISH JOURNAL of CLINICS and LABORATORY
Verified
Journal Article
Open access
ASAyse Kotek Sedef
Ayse Kotek Sedef
EUEmre Uysal
Emre Uysal
TBTANJU BERBER
TANJU BERBER
NGNecla Gürdal
Necla Gürdal
BYBerna Yildirim
Berna Yildirim
Purpose: Graded Prognostic Assessment (GPA) is a new prognostic index for patients with brain metastases. Brain metastasis is a common site of metastasis in lung cancers. Lung cancer-specific GPA scoring system is used. We aimed to assess the prognostic and predictive significance of Graded Prognostic Assessment (GPA) score in non small-cell lung cancer patients with brain metastasis. Materials and Methods: This study was designed as a hospital-based retrospective observational case-series study. A total of 95 patients with brain metastatic NSCLC patients who were followed in two different oncology centers in Turkey between 2015 and 2021 have been included into this study. They were divided into 3 groups according to their GPA scores. Results: The median age of the patients was 62 (range 44-89) years The patients were divided into 3 groups according to their GPA scores. 24 (25.2 %) patients had ‘’0-1’’ GPA score, 54 (56,8 %) patients had ‘’1,5-2’’ GPA score and 17 (18 %) patients had ‘’2,5-3’’ GPA score. The median follow-up time was 11 months and 89 (93.7%) patients died during follow-up. Overall survival (OS) was 8 months. Patients in the low (0-1) GPA scores had worst overall survival than those with higher GPA scores (4.7, 12.6 and 18.5 months respectively and p=0,001). Conclusion: In this study, we have shown that GPA score is useful in evaluating the prognosis of NSCLC patients with brain metastasis

4 August 2020 in The Clinical Respiratory Journal
Verified
Journal Article
Closed access
PDF file
BSBilgehan Sahin
Bilgehan Sahin
BABanu Atalar
Banu Atalar
ESEsra Kaytan Saglam
Esra Kaytan Saglam
ZAZuleyha Akgun
Zuleyha Akgun
UAUfuk Abacioglu
Ufuk Abacioglu
SASerap Akyurek
Serap Akyurek